Paclitaxel with inhibitor of apoptosis antagonist, LCL161, for localized triple-negative breast cancer, prospectively stratified by gene signature in a biomarker-driven neoadjuvant trial

1. Bardia, A.
2. Parton, M.
3. Kummel, S.
4. Estevez, L.G.
5. Huang, C.-S.
6. Cortes, J.
7. Ruiz-Borrego, M.
8. Telli, M.L.
9. Martin-Martorell, P.
10. Lopez, R.
11. Beck, J.T.
12. Ismail-Khan, R.
13. Chen, S.-C.
14. Hurvitz, S.A.
15. Mayer, I.A.
16. Carreon, D.
17. Cameron, S.
18. Liao, S.
19. Baselga, J.
20. Kim, S.-B.